ACADIA Pharmaceuticals Inc at Bank of America Global Healthcare Conference Transcript
Good morning. Welcome to the Bank of America Healthcare Conference. I'm Tazeen Ahmad. I'm one of the Senior (inaudible) Analyst here. It's my pleasure to have our next presenting company, ACADIA Pharmaceuticals with me up here on stage. To my right is Steve Davis, who is, of course, CEO of the company. And to my left is Mark Schneyer, who is CFO. Steve and Mark, good morning. Thanks for coming to Vegas.
So maybe we could start off, Steve, with a quick overview of ACADIA, a 2-minute elevator pitch on the company, its background and then we can go straight into Q&A.
Perfect. So I'll try to keep it in 2 minutes and then we can spend a productive time in Q&A. So 4 things I'll touch on this morning. We have 2 commercial products today, NUPLAZID for Parkinson's disease psychosis and Daybue for Rett syndrome. So I'll give you just a brief snippet on each of those, and I'll talk about a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
